dog |
LDLo |
intravenous |
3mg/kg (3mg/kg) |
GASTROINTESTINAL: OTHER CHANGES
BLOOD: OTHER CHANGES |
Cancer Chemotherapy Reports, Part 2. Vol. 2, Pg. 201, 1965. |
man |
TDLo |
oral |
3571ug/kg (3.571mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 361, 1983. |
monkey |
LDLo |
intravenous |
3mg/kg (3mg/kg) |
GASTROINTESTINAL: OTHER CHANGES
BLOOD: OTHER CHANGES |
Cancer Chemotherapy Reports, Part 2. Vol. 2, Pg. 201, 1965. |
mouse |
LD50 |
intraperitoneal |
20mg/kg (20mg/kg) |
|
British UK Patent Application. Vol. #2028335, |
mouse |
LD50 |
oral |
80mg/kg (80mg/kg) |
|
British UK Patent Application. Vol. #2028335, |
mouse |
LD50 |
subcutaneous |
26mg/kg (26mg/kg) |
|
British UK Patent Application. Vol. #2028335, |
rat |
LD50 |
intracrebral |
> 400ug/kg (0.4mg/kg) |
|
Journal of Pharmacy and Pharmacology. Vol. 18, Pg. 760, 1966. |
rat |
LD50 |
intraperitoneal |
14mg/kg (14mg/kg) |
|
Biochemical Pharmacology. Vol. 13, Pg. 969, 1964. |
rat |
LD50 |
oral |
76mg/kg (76mg/kg) |
|
Food and Chemical Toxicology. Vol. 22, Pg. 665, 1984. |
rat |
LDLo |
subcutaneous |
32mg/kg (32mg/kg) |
|
European Journal of Cancer. Vol. 13, Pg. 873, 1977. |
women |
TDLo |
oral |
82600ug/kg (82.6mg/kg) |
LUNGS, THORAX, OR RESPIRATION: FIBROSIS (INTERSTITIAL)
LUNGS, THORAX, OR RESPIRATION: COUGH
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Cancer Vol. 41, Pg. 455, 1978. |